Comparison of One-Tier and Two-Tier Newborn Screening Metrics for Congenital Adrenal Hyperplasia
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Newborn screening (NBS) for the classic forms of congenital adrenal hyperplasia (CAH) is mandated in all states in the United States. Compared with other NBS disorders, the false-positive rate (FPR) of CAH screening remains high and has not been significantly improved by adjusting 17α-hydroxyprogesterone cutoff values for birth weight and/or gestational age. Minnesota was the first state to initiate, and only 1 of 4 states currently performing, second-tier steroid profiling for CAH. False-negative rates (FNRs) for CAH are not well known. METHODS: This is a population-based study of all Minnesota infants (769,834) born 1999-2009, grouped by screening protocol (one-tier with repeat screen, January 1999 to May 2004; two-tier with second-tier steroid profiling, June 2004 to December 2009). FPR, FNR, and positive predictive value (PPV) were calculated per infant, rather than per sample, and compared between protocols. RESULTS: Overall, 15 false-negatives (4 salt-wasting, 11 simple-virilizing) and 45 true-positives were identified from 1999 to 2009. With two-tier screening, FNR was 32%, FPR increased to 0.065%, and PPV decreased to 8%, but these changes were not statistically significant. Second-tier steroid profiling obviated repeat screens of borderline results (355 per year average). CONCLUSIONS: In comparing the 2 screening protocols, the FPR of CAH NBS remains high, the PPV remains low, and false-negatives occur more frequently than has been reported. Physicians should be cautioned that a negative NBS does not necessarily rule out classic CAH; therefore, any patient for whom there is clinical concern for CAH should receive immediate diagnostic testing.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Screening a second sample several days later also improves both sensitivity and positive predictive value (47,61,68).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [68]
In the citing paper
“This strategy was used in actual practice as the second-tier screen in Minnesota for 3 years (204,000 births) and improved the positive predictive value of the CAH screen (82), but subsequent reports from the same center suggested that this approach was inferior to testing a second sample by routine immunoassay (67,68).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [68]
Citations
Cites
Interval Estimation for a Binomial Proportion
Brown, L. D., Cai, T. T., & DasGupta, A. (2001) · Statistical Science · doi:10.1214/ss/1009213286 · Cited by 3,538
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency*
White, P. C., & Speiser, P. W. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.3.0398 · Cited by 1,432
Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
White, P. C. (2000) · Endocrine Reviews · doi:10.1210/er.21.3.245 · Cited by 877
Waisbren, S. E. (2003) · JAMA · doi:10.1001/jama.290.19.2564 · Cited by 360
Therrell, B. L., Berenbaum, S. A., Manter-Kapanke, V., Simmank, J., Korman, K., Prentice, L., Gonzalez, J., & Gunn, S. (1998) · Pediatrics · doi:10.1542/peds.101.4.583 · Cited by 344
PANG, S., HOTCHKISS, J., DRASH, A. L., LEVINE, L. S., & NEW, M. I. (1977) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-45-5-1003 · Cited by 293
Expanded Newborn Screening for Biochemical Disorders: The Effect of a False-Positive Result
Gurian, E. A., Kinnamon, D. D., Henry, J. J., & Waisbren, S. E. (2006) · Pediatrics · doi:10.1542/peds.2005-2294 · Cited by 223
Lacey, J. M., Minutti, C. Z., Magera, M. J., Tauscher, A. L., Casetta, B., McCann, M., Lymp, J., Hahn, S. H., Rinaldo, P., & Matern, D. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.027193 · Cited by 216
Self-citationWong, T., Shackleton, C. H., Covey, T. R., & Ellis, G. (1992) · Clinical Chemistry · doi:10.1093/clinchem/38.9.1830 · Cited by 159
Allen, D. B., Hoffman, G. L., Fitzpatrick, P., Laessig, R., Maby, S., & Slyper, A. (1997) · The Journal of Pediatrics · doi:10.1016/s0022-3476(97)70321-4 · Cited by 153
Cited by
Speiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
Inborn errors of metabolism and expanded newborn screening: review and update
Mak, C. M., Lee, H.-C. H., Chan, A. Y.-W., & Lam, C.-W. (2013) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2013.847896 · Cited by 201
Congenital Adrenal Hyperplasia
Witchel, S. F. (2017) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2017.04.001 · Cited by 184
Congenital Adrenal Hyperplasia
Witchel, S. F., & Azziz, R. (2011) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2010.10.001 · Cited by 161
Expanded newborn screening by mass spectrometry: New tests, future perspectives
Ombrone, D., Giocaliere, E., Forni, G., Malvagia, S., & la Marca, G. (2015) · Mass Spectrometry Reviews · doi:10.1002/mas.21463 · Cited by 154
Gidlöf, S., Wedell, A., Guthenberg, C., von Döbeln, U., & Nordenström, A. (2014) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2013.5321 · Cited by 119
Güran, T., Tezel, B., Çakır, M. D., Akıncı, A., Orbak, Z., Keskın, M., Eklioğlu, B. S., Özön, A., Özbek, M. N., Karagüzel, G., et al. (2020) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2020.2019.0182 · Cited by 81
Biochemical and genetic diagnosis of 21-hydroxylase deficiency
Falhammar, H., Wedell, A., & Nordenström, A. (2015) · Endocrine · doi:10.1007/s12020-015-0731-6 · Cited by 80
“program using the second-tier strategy [81, 82].”
Newborn Screening for Congenital Adrenal Hyperplasia: Review of Factors Affecting Screening Accuracy
Held, P. K., Bird, I. M., & Heather, N. L. (2020) · International Journal of Neonatal Screening · doi:10.3390/ijns6030067 · Cited by 79
Newborn screening for congenital adrenal hyperplasia in New Zealand, 1994-2013
Heather, N. L., Seneviratne, S. N., Webster, D., Derraik, J. G. B., Jefferies, C., Carll, J., Jiang, Y., Cutfield, W. S., & Hofman, P. L. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3168 · Cited by 65
Optimizing Newborn Screening for Congenital Adrenal Hyperplasia
White, P. C. (2013) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2013.02.008 · Cited by 56
Tsuji, A., Konishi, K., Hasegawa, S., Anazawa, A., Onishi, T., Ono, M., Morio, T., Kitagawa, T., & Kashimada, K. (2015) · BMC Pediatrics · doi:10.1186/s12887-015-0529-y · Cited by 48
Determination of a steroid profile in heel prick blood using LC-MS/MS
Boelen, A., Ruiter, A. F., Claahsen-van der Grinten, H. L., Endert, E., & Ackermans, M. T. (2016) · Bioanalysis · doi:10.4155/bio.16.6 · Cited by 49
Congenital adrenal hyperplasia cases identified by newborn screening in one- and two-screen states
Held, P. K., Shapira, S. K., Hinton, C. F., Jones, E., Hannon, W. H., & Ojodu, J. (2015) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2015.08.004 · Cited by 44
Newborn screening for congenital adrenal hyperplasia in New York State
Pearce, M., DeMartino, L., McMahon, R., Hamel, R., Maloney, B., Stansfield, D.-M., McGrath, E. C., Occhionero, A., Gearhart, A., Caggana, M., et al. (2016) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2016.02.005 · Cited by 36
Ethnic variability in newborn metabolic screening markers associated with false‐positive outcomes
Peng, G., Tang, Y., Gandotra, N., Enns, G. M., Cowan, T. M., Zhao, H., & Scharfe, C. (2020) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12236 · Cited by 42
Current and Novel Treatment Strategies in Children with Congenital Adrenal Hyperplasia
Nordenström, A., Falhammar, H., & Lajić, S. (2022) · Hormone Research in Paediatrics · doi:10.1159/000522260 · Cited by 41
Kopacek, C., de Castro, S. M., Prado, M. J., da Silva, C. M. D., Beltrão, L. A., & Spritzer, P. M. (2017) · BMC Pediatrics · doi:10.1186/s12887-016-0772-x · Cited by 36
Guidelines for diagnosis and treatment of 21-hydroxylase deficiency (2014 revision)
Ishii, T., Anzo, M., Adachi, M., Onigata, K., Kusuda, S., Nagasaki, K., Harada, S., Horikawa, R., Minagawa, M., Minamitani, K., et al. (2015) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.24.77 · Cited by 44
Pode‐Shakked, N., Blau, A., Pode‐Shakked, B., Tiosano, D., Weintrob, N., Eyal, O., Zung, A., Levy‐Khademi, F., Tenenbaum‐Rakover, Y., Zangen, D., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02468 · Cited by 42
Comparison of newborn screening protocols for congenital adrenal hyperplasia in preterm infants
Sarafoglou, K., Gaviglio, A., Hietala, A., Frogner, G., Banks, K., McCann, M., & Thomas, W. (2014) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2014.01.038 · Cited by 38
Self-citationSpeiser, P., Chawla, R., Chen, M., Diaz-Thomas, A., Finlayson, C., Rutter, M., Sandberg, D., Shimy, K., Talib, R., Cerise, J., et al. (2020) · International Journal of Neonatal Screening · doi:10.3390/ijns6020037 · Cited by 36
Reduced Activity of 11β-Hydroxylase Accounts for Elevated 17α-Hydroxyprogesterone in Preterms
Kamrath, C., Hartmann, M. F., Boettcher, C., & Wudy, S. A. (2014) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2014.04.011 · Cited by 36
Precursor-to-product ratios reflect biochemical phenotype in congenital adrenal hyperplasia
Hicks, R. A., Yee, J. K., Mao, C. S., Graham, S., Kharrazi, M., Lorey, F., & Lee, W. P. (2014) · Metabolomics · doi:10.1007/s11306-013-0558-1 · Cited by 35
Kamrath, C., Hartmann, M. F., Boettcher, C., Zimmer, K.-P., & Wudy, S. A. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.10.013 · Cited by 34
Stroek, K., Ruiter, A. F. C., van der Linde, A., Ackermans, M. T., Bouva, M. J., Engel, H., Jakobs, B. S., Kemper, E. A., van den Akker, E. L. T., van Albada, M. E., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab464 · Cited by 34
Neonatal Screening for Congenital Adrenal Hyperplasia in Turkey: A Pilot Study with 38,935 Infants
Güran, T., Tezel, B., Gürbüz, F., Eklioğlu, B. S., Hatipoğlu, N., Kara, C., Aydın, M., Şimşek, E., Çizmecioğlu, F. M., Özön, A., et al. (2018) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2018.2018.0117 · Cited by 32
Results from 28 Years of Newborn Screening for Congenital Adrenal Hyperplasia in Sapporo
Morikawa, S., Nakamura, A., Fujikura, K., Fukushi, M., Hotsubo, T., Miyata, J., Ishizu, K., & Tajima, T. (2014) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.23.35 · Cited by 26
Outcome of Newborn Screening for Congenital Adrenal Hyperplasia at Two Time Points
Eshragh, N., Doan, L. V., Connelly, K. J., Denniston, S., Willis, S., & LAFRANCHI, S. H. (2020) · Hormone Research in Paediatrics · doi:10.1159/000508075 · Cited by 30
A three-year follow-up of congenital adrenal hyperplasia newborn screening
Pezzuti, I. L., Barra, C. B., Mantovani, R. M., Januário, J. N., & Silva, I. N. (2014) · Jornal de Pediatria · doi:10.1016/j.jped.2013.09.007 · Cited by 26
Bialk, E. R., Lasarev, M. R., & Held, P. K. (2019) · International Journal of Neonatal Screening · doi:10.3390/ijns5030033 · Cited by 25
Neonatal mass screening for 21-hydroxylase deficiency
Tajima, T., & Fukushi, M. (2016) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.25.1 · Cited by 25
Neonatal Screening for Congenital Adrenal Hyperplasia in Denmark: 10 Years of Experience
Lind‐Holst, M., Bækvad‐Hansen, M., Berglund, A., Cohen, A. S., Melgaard, L., Skogstrand, K., Dunø, M., Main, K. M., HOUGAARD, D. M., Gravholt, C. H., et al. (2022) · Hormone Research in Paediatrics · doi:10.1159/000522230 · Cited by 24
Grosse, S. D., & Vliet, G. V. (2020) · International Journal of Neonatal Screening · doi:10.3390/ijns6040082 · Cited by 22
Greene, C. N., Cordovado, S. K., Turner, D. P., Keong, L. M., Shulman, D., & Mueller, P. W. (2014) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2014.07.002 · Cited by 19
Tieh, P. Y., Yee, J. K., Hicks, R. A., Mao, C. S., & Lee, W.-N. (2017) · Journal of Perinatology · doi:10.1038/jp.2016.223 · Cited by 19
Application of principal component analysis to newborn screening for congenital adrenal hyperplasia
Lasarev, M. R., Bialk, E. R., Allen, D. B., & Held, P. K. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa371 · Cited by 19
Nokoff, N., Buchanan, C., & Barker, J. M. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae563 · Cited by 19
Zhan, X., Han, L., Qiu, W., Gu, X., Guo, J., Chang, S., Wang, Y., & Zhang, H. (2022) · Steroids · doi:10.1016/j.steroids.2022.109056 · Cited by 19
de Hora, M. R., Heather, N. L., Patel, T., Bresnahan, L. G., WEBSTER, D. R., & Hofman, P. L. (2021) · Clinical Endocrinology · doi:10.1111/cen.14422 · Cited by 17
de Hora, M. R., Heather, N. L., WEBSTER, D. R., Albert, B. B., & Hofman, P. L. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1226284 · Cited by 15
du Toit, T., Finken, M. J. J., Hamer, H. M., Heijboer, A. C., & Swart, A. C. (2018) · Steroids · doi:10.1016/j.steroids.2018.06.003 · Cited by 12
de Hora, M. R., Heather, N. L., WEBSTER, D. R., Albert, B. B., & Hofman, P. L. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab383 · Cited by 11
A genetic epidemiology study of congenital adrenal hyperplasia in Italy
Gialluisi, A., Menabò, S., Baldazzi, L., Casula, L., Meloni, A., Farci, M., Mariotti, S., Balestrino, L., Ortolano, R., Murru, S., et al. (2017) · Clinical Genetics · doi:10.1111/cge.13078 · Cited by 11
Hiperplasia adrenal congénita por déficit de 21 hidroxilasa: un reto diagnóstico y terapéutico
Latorre, S. I., Garzón, C., Manosalva, G., Merchán, S., Jacomussi-Alzate, L., & Maldonado, S. (2016) · Revista Repertorio de Medicina y Cirugía · doi:10.1016/j.reper.2016.05.001 · Cited by 10
Sarafoglou, K., Gaviglio, A., Wolf, C., Lorentz, C. P., Lteif, A., Kyllo, J., Radloff, G., Detwiler, Z., Cuthbert, C. D., Hodges, J. S., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae297 · Cited by 8
“The later the timing of the collection of an NBS or serum confirmation sample from affected infants, the higher the 17OHP concentration (3–5).”
Self-citationDörr, H. G., Odenwald, B., & Nennstiel, U. (2015) · International Journal of Neonatal Screening · doi:10.3390/ijns1010036 · Cited by 9
Changing perspectives in screening for congenital hypothyroidism and congenital adrenal hyperplasia
Mitchell, M. L., Hsu, H.-W., & Sahai, I. (2013) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000028 · Cited by 8
Delayed-Onset ADA1 (ADA) Deficiency Not Detected by TREC Screen
Kahwash, B. M., Yonkof, J. R., Abraham, R. S., Mustillo, P., Abu‐Arja, R., Rangarajan, H. G., & Scherzer, R. (2021) · PEDIATRICS · doi:10.1542/peds.2020-005579 · Cited by 8
Association of Maternal Age and Blood Markers for Metabolic Disease in Newborns
Xie, Y., Peng, G., Zhao, H., & Scharfe, C. (2023) · Metabolites · doi:10.3390/metabo14010005 · Cited by 7
Yauch, L. M., Mayhew, A., Gomez‐Lobo, V., Shimy, K., & Sarafoglou, K. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa169 · Cited by 5
Self-citationPeng, G., Zhang, Y., Zhao, H., & Scharfe, C. (2022) · International Journal of Neonatal Screening · doi:10.3390/ijns8030048 · Cited by 5
Multiple 17-OHP Cutoff Co-Variates Fail to Improve 21-Hydroxylase Deficiency Screening Accuracy
Matharu, P. K., Held, P. K., & Allen, D. B. (2022) · International Journal of Neonatal Screening · doi:10.3390/ijns8040057 · Cited by 5
Ladjouze, A., Ouarezki, Y., Djermane, A., Kherra, S., Meriem, B., Mohammedi, K., Douiri, D., Boutaghane, N., Bouzerar, Z., & Vliet, G. V. (2025) · Hormone Research in Paediatrics · doi:10.1159/000543430 · Cited by 3
Newborn Screening: What Does the Emergency Physician Need to Know?
Roofe, L. R., Higby, N., & Abramo, T. J. (2015) · Pediatric Emergency Care · doi:10.1097/pec.0000000000000549 · Cited by 4
A three-year follow-up of congenital adrenal hyperplasia newborn screening
Pezzuti, I. L., Barra, C. B., Mantovani, R. M., Januário, J. N., & Silva, I. N. (2014) · Jornal de Pediatria (Versão em Português) · doi:10.1016/j.jpedp.2013.08.006 · Cited by 3
Carvalho, D. F., Lima‐Valassi, H. P., Hayashi, G. Y., Oliveira, A. C. M., Matias, G. D. S. S., Alves, A. N. L., de Miranda, M. C., Funari, M. F. A., Madureira, G., Latronico, A. C., et al. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag107 · Cited by 2
Neugeborenes mit intersexuellem Genitale bei unauffälligem Neugeborenenscreening
Sydlik, C., Ermer, U., Odenwald, B., & Schmidt, H. (2016) · Monatsschrift Kinderheilkunde · doi:10.1007/s00112-016-0150-7 · Cited by 2
Cribado neonatal de la hiperplasia suprarrenal congénita. Revisión sistemática
Paz-Valiñas, L., Lema, L. V., & Merino, G. A. (2014) · RUNA. Repositorio Institucional del Sergas (Servicio Gallego de Salud (SERGAS)) · Cited by 3
Senarathne, U. D., Abdelmeguid, Y., Raafat, S., Doery, J. C. G., & Falhammar, H. (2023) · Springer eBooks · doi:10.1007/978-3-319-66816-1_1805-1 · Cited by 1
Diagnosis and therapies for mucopolysaccharidoses
Kubaski, F. (2017) · Library, Museums and Press - UDSpace (University of Delaware) · doi:10.58088/ket7-a919 · Cited by 1
Editorial: Neonatal Screening for Congenital Adrenal Hyperplasia in Turkey
Bereket, A. (2019) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2019.2019.0001 · Cited by 1
Kopacek, C. (2016) · Americanae (AECID Library)
17-hydroxyprogesterone levels in blood from the heels of healthy full-term newborns
de Santander, U. I., Mora-Bautista, V. M., Martinez‐Paredes, J. F., de Santander, U. I., Calderón-Rojas, A. L., de Santander, U. I., Gómez-Tarazona, C. A., de Santander, U. I., Pinzón-Mantilla, K., Mora, G. M., et al. (2017) · CES Medicina · doi:10.21615/cesmedicina.31.2.1
Pecularities of congenital adrenal hyperplasia replacement therapy in children
Zelinska, N., Погадаєва, Н. Л., Вікторівна, Г. Є., & Шевченко, І. Ю. (2014) · Clinical endocrinology and endocrine surgery · doi:10.24026/1818-1384.1(46).2014.75358
Problems of neonatal screening on congenital adrenal hyperplasia
Zelinska, N., Погадаєва, Н. Л., Вікторівна, Г. Є., Ніфонтова, Л. В., & Орлова, Т. О. (2013) · Clinical endocrinology and endocrine surgery · doi:10.24026/1818-1384.2(43).2013.77677
de Carvalho, D. F. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2017.tde-04082017-113148
21-hydroxylase deficiency and fertility
Amiraslanova, M. M., & Kuznetsova, I. V. (2020) · Medical alphabet · doi:10.33667/2078-5631-2020-4-16-26
ADRENOGENITAL SYNDROME IN WOMEN (LITERATURE REVIEW)
Iliushina, A. A., Ляшук, П. М., Protsenko, O. V., Lenkovska, G. S., & Vatamaniuk, M. M. (2014) · Clinical & experimental pathology · doi:10.24061/1727-4338.xiii.1.47.2014.46
21-Hydroxylase Deficiency: Clinical and Biochemical Aspects
Nordenström, A., & Lajić, S. (2019) · Encyclopedia of Endocrine Diseases · doi:10.1016/b978-0-12-801238-3.65208-x
21-Hydroxylase deficiency: Clinical and biochemical aspects
Nordenström, A., & Lajić, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00171-0
Jafar, B., Kilberg, M. J., & Vogiatzi, M. G. (2025) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2025.114597
de Carvalho, D. U. O. G. (2017) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Bautista, V. M. M. (2016) · Universidad Industrial de Santander
Tuli, G., Munarin, J., Pavanello, E., & SANCTIS, L. D. (2026) · Endocrine · doi:10.1007/s12020-026-04759-5
Дефицит 21-гидроксилазы и фертильность
М., А. М., & Н., К. И. (2020) · Medical alphabet
Metadata
- Authors
- Sarafoglou, K., Banks, K., Gaviglio, A., Hietala, A., McCann, M., & Thomas, W.
- Affiliations
- University of Minnesota (US)
- Minnesota Department of Health (US)
- Venue
- PEDIATRICS
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2012-11-01
- Volume
- 130
- Issue
- 5
- Pages
- e1261-e1268
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2156177778
- Cited by
- 69
- References
- 29
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 2 · 2023: 3 · 2022: 5 · 2021: 4 · 2020: 9 · 2019: 4 · 2018: 4 · 2017: 4 · 2016: 6 · 2015: 8 · 2014: 9 · 2013: 5
- FWCI
- 2.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- PEDIATRICS (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- congenital adrenal hyperplasia, newborn screening, false positive rate, false negative rate, positive predictive value, 17-hydroxyprogesterone, repeat screening, salt-wasting CAH, simple virilizing CAH
- MeSH terms
- Adrenal Hyperplasia, Congenital, Clinical Protocols, Female, Humans, Infant, Newborn, Male, Retrospective Studies, Neonatal Screening
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.